{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:25:16Z","timestamp":1791206716371,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.yjmcc.2008.12.023","type":"journal-article","created":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T13:31:28Z","timestamp":1232544688000},"page":"998-1007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Anti-hypertrophic effect of NHE-1 inhibition involves GSK-3\u03b2-dependent attenuation of mitochondrial dysfunction"],"prefix":"10.1016","volume":"46","author":[{"given":"Sabzali","family":"Javadov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatesh","family":"Rajapurohitam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Kili\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asad","family":"Zeidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morris","family":"Karmazyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2008.12.023_bib1","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1161\/CIRCULATIONAHA.106.626929","article-title":"Sodium-hydrogen exchanger, cardiac overload, and myocardial hypertrophy","volume":"115","author":"Cingolani","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2008.12.023_bib2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.yjmcc.2008.01.005","article-title":"The role of NHE-1 in myocardial hypertrophy and remodelling","volume":"44","author":"Karmazyn","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00210-003-0808-2","article-title":"NHE-1 inhibition: from protection during acute ischaemia\/reperfusion to prevention\/reversal of myocardial remodelling","volume":"368","author":"Linz","year":"2003","journal-title":"Naunyn-Schmiedeberg's. Arch. Pharmacol."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cardiores.2004.04.014","article-title":"Inhibition of the Na+\/H+ exchanger attenuates the deterioration of ventricular function during pacing-induced heart failure in rabbits","volume":"63","author":"Aker","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib5","doi-asserted-by":"crossref","first-page":"H381","DOI":"10.1152\/ajpheart.00602.2003","article-title":"Inhibition and reversal of myocardial infarction-induced hypertrophy and heart failure by NHE-1 inhibition","volume":"286","author":"Chen","year":"2004","journal-title":"Am. J. Physiol, Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/01.HYP.0000051502.93374.1C","article-title":"Regression of hypertensive myocardial fibrosis by Na+\/H+ exchange inhibition","volume":"41","author":"Cingolani","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2008.12.023_bib7","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/sj.bjp.0705631","article-title":"Na+\/H+ exchange inhibition attenuates left ventricular remodeling and preserves systolic function in pressure-overloaded hearts","volume":"141","author":"Marano","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.yjmcc.2004.10.007","article-title":"NHE-1 inhibition improves impaired mitochondrial permeability transition and respiratory function during postinfarction remodelling in the rat","volume":"38","author":"Javadov","year":"2005","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib9","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0008-6363(03)00533-9","article-title":"Mitochondrial permeability transition pore opening during myocardial reperfusion\u2014a target for cardioprotection","volume":"61","author":"Halestrap","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib10","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/j.1742-4658.2006.05213.x","article-title":"The mitochondrial permeability transition from in vitro artifact to disease target","volume":"273","author":"Bernardi","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000103747","article-title":"Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection","volume":"20","author":"Javadov","year":"2007","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib12","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1124\/jpet.105.100107","article-title":"Antihypertrophic effect of Na+\/H+ exchanger isoform 1 inhibition is mediated by reduced mitogen-activated protein kinase activation secondary to improved mitochondrial integrity and decreased generation of mitochondrial-derived reactive oxygen species","volume":"317","author":"Javadov","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/35096075","article-title":"The renaissance of GSK3","volume":"2","author":"Cohen","year":"2001","journal-title":"Nat. Rev., Mol. Cell Biol."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1432-1033.1983.tb07140.x","article-title":"Glycogen synthase from rabbit skeletal muscle; effect of insulin on the state of phosphorylation of the seven phosphoserine residues in vivo","volume":"130","author":"Parker","year":"1983","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0301-0082(01)00011-9","article-title":"The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling","volume":"65","author":"Grimes","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib16","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1073\/pnas.231619298","article-title":"Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo","volume":"99","author":"Antos","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1083\/jcb.151.1.117","article-title":"Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy","volume":"151","author":"Haq","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib18","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/01.RES.0000018952.70505.F1","article-title":"Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development","volume":"90","author":"Hardt","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib19","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1172\/JCI19906","article-title":"Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore","volume":"113","author":"Juhaszova","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib20","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1517\/14728222.9.3.447","article-title":"Inhibition of GSK-3beta as a target for cardioprotection: the importance of timing, location, duration and degree of inhibition","volume":"9","author":"Murphy","year":"2005","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.yjmcc.2008.12.023_bib21","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.yjmcc.2007.08.010","article-title":"Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection","volume":"43","author":"Nishihara","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib22","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.bcp.2006.03.005","article-title":"AMP-activated protein kinase (AMPK) activating agents cause dephosphorylation of Akt and glycogen synthase kinase-3","volume":"71","author":"King","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.bcp.2007.08.028","article-title":"AICAR positively regulate glycogen synthase activity and LDL receptor expression through Raf-1\/MEK\/p42\/44 MAPK\/p90RSK\/GSK-3 signaling cascade","volume":"75","author":"Wang","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib24","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/01.RES.0000258446.23525.37","article-title":"AMP-activated protein kinase in the heart: role during health and disease","volume":"100","author":"Arad","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1113\/jphysiol.2006.109389","article-title":"AMPK alterations in cardiac physiology and pathology: enemy or ally?","volume":"574","author":"Dyck","year":"2006","journal-title":"J. Physiol."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib26","doi-asserted-by":"crossref","first-page":"H300","DOI":"10.1152\/ajpheart.2000.278.1.H300","article-title":"Na+\/H+ exchange inhibition attenuates hypertrophy and heart failure in 1-wk postinfarction rat myocardium","volume":"278","author":"Yoshida","year":"2000","journal-title":"Am. J. Physiol, Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib27","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/nm1137","article-title":"Adiponectin-mediated modulation of hypertrophic signals in the heart","volume":"10","author":"Shibata","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib28","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1074\/jbc.M506850200","article-title":"Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase alpha-subunits in heart via hierarchical phosphorylation of Ser485\/491","volume":"281","author":"Horman","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib29","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1242\/jcs.01540","article-title":"The AMP-activated protein kinase pathway\u2014new players upstream and downstream","volume":"117","author":"Hardie","year":"2004","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib30","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/hc4001.097183","article-title":"Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy","volume":"104","author":"Tian","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2008.12.023_bib31","doi-asserted-by":"crossref","first-page":"32771","DOI":"10.1074\/jbc.M403528200","article-title":"Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte","volume":"279","author":"Chan","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib32","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1295","article-title":"Adiponectin protects against myocardial ischemia\u2013reperfusion injury through AMPK- and COX-2-dependent mechanisms","volume":"11","author":"Shibata","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00424-006-0124-z","article-title":"AICAR inhibits the Na+\/H+ exchanger in rat hearts\u2014possible contribution to cardioprotection","volume":"453","author":"Moopanar","year":"2006","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib34","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1210\/en.2007-1326","article-title":"5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside reduces glucose uptake via the inhibition of Na+\/H+ exchanger 1 in isolated rat ventricular cardiomyocytes","volume":"149","author":"Segalen","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.yjmcc.2008.12.023_bib35","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1161\/CIRCULATIONAHA.105.542209","article-title":"Enhanced activity of the myocardial Na+\/H+ exchanger NHE-1 contributes to cardiac remodeling in atrial natriuretic peptide receptor-deficient mice","volume":"112","author":"Kilic","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2008.12.023_bib36","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIRCULATIONAHA.107.755066","article-title":"Inhibition of GSK3\u03b2 by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion","volume":"117","author":"Gomez","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2008.12.023_bib37","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.yjmcc.2006.01.024","article-title":"Bradykinin prevents reperfusion injury by targeting mitochondrial permeability transition pore through glycogen synthase kinase 3beta","volume":"40","author":"Park","year":"2006","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1006\/bbrc.1995.1491","article-title":"Mitochondrial VDAC can be phosphorylated by cyclic AMP-dependent protein kinase","volume":"209","author":"Bera","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib39","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1161\/01.RES.0000069215.36389.8D","article-title":"Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria","volume":"92","author":"Baines","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2008.12.023_bib40","doi-asserted-by":"crossref","first-page":"10545","DOI":"10.1158\/0008-5472.CAN-05-1925","article-title":"Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity","volume":"65","author":"Pastorino","year":"2005","journal-title":"Cancer Res."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282809000030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282809000030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:20:34Z","timestamp":1758313234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282809000030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0022282809000030"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2008.12.023","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-hypertrophic effect of NHE-1 inhibition involves GSK-3\u03b2-dependent attenuation of mitochondrial dysfunction","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2008.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}